文献速递心境障碍

双相障碍脑脊液蛋白质组图谱

Mapping the Cerebrospinal Fluid Proteome in Bipolar Disorder.
PubMed 文献 · Biol Psychiatry · 2025-01-17

本研究采用纳升液相色谱-高分辨质谱对两个独立临床队列共374人(分别为164例患者+89名对照和66例患者+55名对照)的脑脊液蛋白质组进行定量,发现41种蛋白在兩队列中均呈稳健的病例-对照关联,涉及突触蛋白降低、血脑屏障完整性和补体成分升高,且主要由双相I型驱动。纵向分析显示脑脊液蛋白质组共表达模块的动态变化与疾病严重程度、未来躁狂发作和症状改善相关。

要点

  • 两个独立队列共374人(164例+89名对照;66例+55名对照)的脑脊液蛋白质组中,41种蛋白呈稳健病例-对照关联。
  • 关联表现为突触蛋白(如APP、CLSTN1、NPTX2、NRXN1)和轴突导向/细胞黏附分子降低,血脑屏障完整性和补体成分升高。
  • 纵向分析显示脑脊液蛋白质组共表达模块的动态变化与疾病严重程度、未来躁狂发作和症状改善相关。

核心结论

  • 本研究是双相障碍脑脊液蛋白质组的首个大规模非靶向分析,揭示了潜在生物标志物,并为双相障碍病理中的突触和脑连接过程改变、神经血管完整性受损及补体激活提供了体内证据。

研究设计与样本

  • 采用纳升液相色谱-高分辨质谱对两个独立临床队列共374人的脑脊液蛋白质组进行定量,两个队列分别为164例患者+89名对照和66例患者+55名对照。
  • 部分病例接受纵向随访,中位随访6.5年后重新检查。

主要发现

  • 差异丰度分析显示41种蛋白在两个队列中均呈稳健的病例-对照关联,包括突触蛋白(如APP、CLSTN1、NPTX2、NRXN1)和轴突导向/细胞黏附分子(如NEO1、NCAM1、SEMA7A)水平降低,血脑屏障完整性蛋白(如VTN、SERPIN3)和补体成分(如C1RL、C3、C5)水平升高。
  • 上述发现主要由双相I型亚型驱动;比较双相I型参与者与对照参与者提高了可发现性,尽管统计效力下降,仍揭示86个重复关联。
  • 纵向共表达模块分析显示脑脊液蛋白质组组成的动态变化与临床结局相关,包括疾病严重程度、未来躁狂发作和症状改善。
  • 研究还进行了脑脊液蛋白与双相障碍和精神分裂症遗传风险位点的关联分析。

局限性

  • 比较双相I型参与者与对照参与者时出现统计效力下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bipolar disorder (BD) is a severe psychiatric condition with unclear etiology and no established biomarkers. Here, we aimed to characterize the cerebrospinal fluid (CSF) proteome in euthymic individuals with BD to identify potential protein biomarkers. METHODS: We used nano-flow liquid chromatography coupled to high-resolution mass spectrometry to quantify over 2000 CSF proteins in 374 individuals from two independent clinical cohorts (n = 164 cases + 89 controls and 66 cases + 55 controls, respectively). A subset of the cases was followed longitudinally and reexamined after a median of 6.5 years. RESULTS: Differential abundance analysis revealed 41 proteins with robust case-control association in both cohorts. These included lower levels of synaptic proteins (e.g., APP, CLSTN1, NPTX2, NRXN1) and axon guidance and cell adhesion molecules (e.g., NEO1, NCAM1, SEMA7A) and higher levels of blood-brain barrier integrity proteins (e.g., VTN, SERPIN3) and complement components (e.g., C1RL, C3, C5). The findings were consistently driven by the BD type 1 subtype. Comparing BD type 1 participants with control participants increased discoverability, revealing 86 replicated associations despite a loss of statistical power. Moreover, longitudinal analyses of coexpression modules revealed dynamic changes in the CSF proteome composition that correlated with clinical outcomes, including disease severity, future manic episodes, and symptom improvement. Finally, we conducted association analyses of CSF proteins with genetic risk loci for BD and schizophrenia. CONCLUSIONS: This study represents the first large-scale untargeted profiling of the CSF proteome in BD, unveiling potential biomarkers and providing in vivo support for altered synaptic and brain connectivity processes, impaired neurovascular integrity, and complement activation in the pathology of BD.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Göteson A, Holmén-Larsson J, Celik H, et al. Mapping the Cerebrospinal Fluid Proteome in Bipolar Disorder. Biol Psychiatry. 2025. PMID: 39827936. doi:10.1016/j.biopsych.2025.01.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。